Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Topical metformin gel is as effective and safe as steroids for treating alopecia areata.

Alopecia areata treatments often don't lead to lasting improvement.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

Weekly Azathioprine Pulse therapy is more effective than Betamethasone Oral Mini-Pulse for hair regrowth in moderate to severe Alopecia Areata.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Baricitinib treatment for severe alopecia areata shows significant improvement by 52 weeks, especially in very severe cases.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Intralesional triamcinolone acetonide is more effective but has a higher relapse rate than platelet-rich plasma for treating alopecia areata.

People with alopecia areata often have low vitamin D levels, which may worsen their hair loss.

80% scalp hair regrowth is a successful treatment for alopecia areata.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Mesalazine showed limited effectiveness in treating children with severe alopecia areata.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

The combination of calcipotriol and PRP is the most effective treatment for alopecia areata.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.